Communication Skills Intervention to Promote Transition Into Survivorship

Active, not recruitingOBSERVATIONAL
Enrollment

314

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Hodgkin's LymphomaDiffuse Large B-cell Lymphoma
Trial Locations (9)

10065

Memorial Sloan Kettering Cancer Center, New York

10591

Memorial Sloan Kettering Cancer Center at Phelps, Sleepy Hollow

11220

Maimonides Medical Center, Brooklyn

11570

Memorial Sloan Kettering Cancer Center at Mercy, Rockville Centre

11725

Memorial Sloan Kettering Cancer Center at Commack, Commack

33606

Tampa General Hospital, Tampa

33612

Moffitt Cancer Center, Tampa

77030

Md Anderson Cancer Center, Houston

07920

Memorial Sloan Kettering at Basking Ridge, Basking Ridge

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Maimonides Medical Center

OTHER

collaborator

H. Lee Moffitt Cancer Center and Research Institute

OTHER

collaborator

Rutgers University

OTHER

collaborator

Tampa General Hospital

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Monash University

OTHER

collaborator

Weill Cornell Medical College in Qatar

OTHER

collaborator

New York Presbyterian Brooklyn Methodist Hospital

OTHER

collaborator

San Francisco State University

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01483664 - Communication Skills Intervention to Promote Transition Into Survivorship | Biotech Hunter | Biotech Hunter